ALS TDI 7th Annual Leadership Summit 2011

Biotech industry leaders from Biogen, Genzyme, and Cytokinetics spoke candidly about their insights and experiences in ALS drug development at a panel discussion convened by conference organizer ALS TDI, an ALS non-profit biotech based in Cambridge, MA.  Panelist also included representatives from a venture capital firm and a new NIH-led effort to innovate within translational medicine.  A full broadcast of the summit can be accessed via a link provided in the article.

Click here to read more.

conf-ALSTDI-leadership-summit disease-als topic-clinical topic-randd
Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail